Clinical Trial Update: Efficacy Study of Rapamycin- vs. Zotarolimus-Eluting Stents to Reduce Coronary Restenosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing sirolimus-eluting (Rapamycin) stents with zotarolimus-eluting stents to reduce restenosis in patients with coronary heart disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease

Drugs mentioned

• Sirolimus-eluting stent (sirolimus-eluting stent)
• Zotarolimus-eluting stent (zotarolimus)

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Coronary Heart Disease | Phase 4 | Status: COMPLETED